Table 3 Correlation between clinical parameters and CYFRA21-1
Clinical characteristics | No. | CYFRA21-1 Median (IQR25–75) | P value |
|---|---|---|---|
All | 203 | 5.26 (1.27–5.24) | |
Age | 0.062 | ||
< 55 years | 111 | 1.75 (0.97–3.85) | |
≥ 55 years | 92 | 2.68 (1.58–6.67) | |
Menopause | 0.059 | ||
Yes | 115 | 1.82 (1.13–4.66) | |
No | 88 | 2.34 (1.42–5.96) | |
Tumor size | 0.8714 | ||
< 5 cm | 76 | 1.96 (1.22–5.79) | |
≥ 5 cm | 127 | 2.20 (1.29–5.03) | |
Subtype | |||
Serous | 144 | 2.43 (1.40–6.01) | 0.0547 |
Mucinous | 16 | 1.55 (0.96–1.89) | |
Endometrioid | 24 | 1.89 (1.09–4.38) | |
Clear cell | 15 | 1.49 (0.99–2.51) | |
M/R | 4 | 1.97 (1.71–2.25) | |
Grade | 0.000* | ||
1 | 34 | 0.99 (0.79–1.76) | |
2 | 37 | 1.41 (1.06–2.11) | |
3 | 132 | 2.795 (1.38–11.12) | |
Stage | 0.000* | ||
I | 33 | 4.05 (0.86–3.99) | |
II | 69 | 2.94 (1.08–2.43) | |
III | 52 | 9.29 (1.17–9.76) | |
IV | 49 | 8.31 (2.24–10.72) | |
Lymph node | 0.000* | ||
Yes | 65 | 5.07 (2.23–11.80) | |
No | 138 | 1.33 (0.77–2.67) | |
Ascites | 0.000* | ||
Yes | 29 | 5.79 (1.97–7.90) | |
No | 174 | 1.50 (0.80–4.07) |